What to Look for in These Biotech Stocks? Threshold Pharma, Seattle Genetics, Chiasma, and Ophthotech

May 18, 2016, 08:38 ET from Chelmsford Park SA

NEW YORK, May 18, 2016 /PRNewswire/ --

The Biotech industry continues to face a wave of challenges, but it does not mean that there are no opportunities ahead. Today, ActiveWallSt.com has on its list these four equities: Threshold Pharmaceuticals Inc. (NASDAQ: THLD), Seattle Genetics Inc. (NASDAQ: SGEN), Chiasma Inc. (NASDAQ: CHMA), and Ophthotech Corp. (NASDAQ: OPHT). Sign up now to receive our free insights and trading alerts at:


Threshold Pharmaceuticals Inc.'s shares gained 0.68%, closing Tuesday's trading session at $0.37. The stock recorded a trading volume of 366,333 shares. The Company's shares have advanced 23.33% in the previous three months and are trading 14.24% below their 50-day moving average. Additionally, shares of Threshold Pharmaceuticals have a Relative Strength Index (RSI) of 40.95. Sign up and activate your free alert on THLD at:

http://www.activewallst.com/ On Tuesday, shares in Seattle Genetics Inc. recorded a trading volume of 2.03 million shares, above their three months average volume of 1.09 million shares. The stock edged 4.73% higher, ending the day at $35.85. The Company's shares have advanced 13.41% in the previous three months. The stock is trading above its 50-day moving average by 1.31%. Furthermore, shares of Seattle Genetics have an RSI of 53.41. The complimentary trade alert on SGEN can be accessed at:

http://www.activewallst.com/ Chiasma Inc.'s stock finished the day 1.06% higher at $2.87 and with a total volume of 380,030 shares traded. The Company's shares are trading below their 50-day moving average by 60.43%. The stock has an RSI of 29.17. Register for free on ActiveWallSt.com and activate the trade alert on CHMA at:


Shares in Ophthotech Corp. ended yesterday's session 1.16% higher at $47.02. The stock recorded a trading volume of 416,558 shares. The Company's shares are trading 4.74% above their 50-day moving average. Moreover, Ophthotech's stock has an RSI of 54.86. OPHT free trade alert is just a click away at:



Active Wall Street: 

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. 

AWS has not been compensated; directly or indirectly; for producing or publishing this document. 


The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA charter holder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.  


AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. 


This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit www.activewallst.com

CONTACT For any questions, inquiries, or comments reach out to us directly at: Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom Email: info@activewallst.com Phone number:  1-858-257-3144

SOURCE Chelmsford Park SA